MHC class II-dependent peptide antigen versus superantigen presentation to T cells

Human Immunology

Volumn 54, Issue 2, 1997, Pages 194-201

  Shoukry, Naglaa H ^a,b   Lavoie, Pascal M ^a,b   Thibodeau, Jacques ^c   D'Souza, Sushila ^a   Sekaly, Rafick P ^a,b  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; LIGAND; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PEPTIDE; SUPERANTIGEN; T LYMPHOCYTE RECEPTOR;

ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

ANTIGEN PRESENTATION; ANTIGENS, BACTERIAL; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; RECEPTORS, ANTIGEN, T-CELL; SUPERANTIGENS; T-LYMPHOCYTES;

EID: 0030796333     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(97)00074-8     Document Type: Review

References (60)

1. Busch R, Mellins ED: Developing and shedding inhibitions: how MHC class II molecules reach maturity. Curr Opin Immunol 8:51, 1996.
2. Cresswell P: Invariant chain structure and MHC class II function. Cell 84:505, 1996.
3. Sadegh-Nasseri S, Germain RN: A role for peptide in determining MHC class II structure. Nature 353:167, 1991.
4. Stern LJ, Wiley DC: The human class II MHC protein HLA-DR1 assembles as empty αβ heterodimers in the absence of antigenic peptide. Cell 68:465, 1992.
5. Neefjes JJ, Ploegh HL: Inhibition of endosomal proteolytic activity by leupeptin blocks surface expression of MHC class II molecules and their conversion to SDS resistant αβ heterodimers in endosomes. EMBO J 11:411, 1992.
6. Viville S, Neefjes JJ, Lotteau V, Dierich A, Lemeur M, Ploegh H, Benoist C, Mathis D: Mice lacking the MHC class II-associated invariant chain. Cell 72:635, 1993.
7. Miyazaki T, Wolf P, Tourne S, Waltzinger C, Dierich A, Barois N, Ploegh H, Benoist C, Mathis D: Mice lacking H2-M complexes, enigmatic elements of the MHC class II peptide-loading pathway. Cell 84:531, 1996.
8. Kotzin BL, Leung DYM, Kappler J, Marrack P: Superantigens and their potential role in human disease. Adv Immunol 54:99, 1993.
9. + T cells in mice tolerant to Staphylococcus aureus enterotoxin B. Nature 349:245, 1991.
10. Micusan VV, Thibodeau J: Superantigens of microbial origin. Semin Immunol 5:3, 1993.
11. Fraser JD: High-affinity binding of staphylococcal enterotoxins A and B to HLA-DR. Nature 339:221, 1989.
12. Seth A, Stern LJ, Ottenhoff THM, Engel I, Owen MJ, Lamb JR, Klausner RD, Wiley DC: Binary and ternary complexes between T-cell receptor, class II MHC and superantigen in vitro. Nature 369:324, 1994.
13. Schad EM, Zaitseva I, Zaitsev VN, Dohlsten M, Kalland T, Schlievert PM, Ohlendorf DH, Svensson LA: Crystal structure of the superantigen staphylococcal enterotoxin type A. EMBO J 14:3292, 1995.
14. Swaminathan S, Furey W, Pletcher J, Sax M: Crystal structure of staphylococcal enterotoxin B, a superantigen. Nature 359:801, 1992.
15. Papageorgiou AC, Acharya KR, Shapiro R, Passalacqua EF, Brehm RD, Tranter HS: Crystal structure of the superantigen enterotoxin C2 from Staphylococcus aureus reveals a zinc-binding site. Structure 3:769, 1995.
16. Acharya KR, Passalacqua EF, Jones EY, Harlos K, Stuart DI, Brehm RD, Tranter HS: Structural basis of superantigen action inferred from crystal structure of toxic-shock syndrome toxin-1. Nature 367:94, 1994.
17. Jardetzky TS, Brown JH, Gorga JC, Stern LJ, Urban RG, Chi Y-I, Stauffacher C, Strominger JL, Wiley DC: Three-dimensional structure of human class II histocompatibility molecule complexed with superantigen. Nature 368: 711, 1994.
18. Kim J, Urban RG, Strominger JL, Wiley DC: Crystallographic structure of toxic shock syndrome toxin-1 complexed with a human class II major histocompatibility molecule HLA-DR1. Science 266:1870, 1994.
19. Thibodeau J, Cloutier I, Lavoie PM, Labrecque N, Mourad W, Jardetzky T, Sekaly R-P: Subsets of HLA-DR1 molecules defined by SEB and TSST-1 binding. Science 266: 1874, 1994.
20. Fraser JD, Urban RG, Strominger JL, Robinson H: Zinc regulates the function of two superantigens. Proc Natl Acad Sci USA 89:5507, 1992.
21. Hudson KR, Tiedemann RE, Urban RG, Lowe SC, Strominger JL, Fraser JD: Staphylococcal enterotoxin A has two cooperative binding sites on major histocompatibility complex class II. J Exp Med 182:711, 1995.
22. Abrahmsen L, Dohlsten M, Segren S, Bjork P, Jonsson E, Kalland T: Characterization of two distinct MHC class II binding sites in the superantigen staphylococcal enterotoxin A. EMBO J 14:2978, 1995.
23. Thibodeau J, Dohlsten M, Cloutier I, et al.: Molecular characterization and role in T cell activation of staphylococcal enterotoxin A binding to the HLA-DRα chain. J Immunol 158:3698, 1997.
24. Thibodeau J, Lavoie PM, Cazenave PA: Bazinc instinct: how SEA attracts MHC class II molecules. Res Immunol 1996 (in press).
25. Brown JH, Jardetzky TS, Gorga JC, Stern LJ, Urban RG, Strominger JL, Wiley DC: Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 364:33, 1993.
26. Dellabona P, Peccoud J, Kappler J, Marrack P, Benoist C, Mathis D: Superantigens interact with MHC class II molecules outside of the antigen groove. Cell 62:1115, 1990.
27. Stern LJ, Brown JH, Jardetzky TS, Gorga JC, Urban RG, Strominger JL, Wiley DC: Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368:215, 1994.
28. Kozono H, Parker D, White J, Marrack P, Kappler J: Multiple binding sites for bacterial superantigens on soluble class II major histocompatibility complex molecules. Immunity 3:187, 1995.
29. Wen R, Cole GA, Surman S, Blackman MA, Woodland DL: Major histocompatibility complex class II-associated peptides control the presentation of bacterial superantigens to T cells. J Exp Med 183:1083, 1996.
30. Verreck FAW, Vermeulen C, Van der Poel A, Jorritsma P, Amons R, Coligan JE, Drijfhout JW, Koning F: The generation of SDS-stable HLA DR dimers is independent of efficient peptide binding. Int Immunol 8:397, 1996.
31. k. Immunol Rev 151:81, 1996.
32. Chicz RM, Urban RG, Lane WS, Gorga JC, Stern LJ, Vignali DAA, Strominger JL: Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogenous in size. Nature 358:764, 1992.
33. Bodmer H, Viville S, Benoist C, Mathis D: Diversity of endogenous epitopes bound to MHC class II molecules limited by invariant chain. Science 263:1284, 1994.
34. b. Science 257: 919, 1992.
35. Madden DR, Garboczi DN, Wiley DC: The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2. Cell 75:693, 1993.
36. Busch R, Cloutier I, Sekaly R-P, Hammerling GJ: Invariant chain protects class II histocompatibility antigens from binding intact polypeptides in the endoplasmic reticulum. EMBO J 15:418, 1996.
37. Mellins E, Kempin S, Smith L, Monji T, Pious D: A gene required for class II-restricted antigen presentation maps to the major histocompatibility complex. J Exp Med 174:1607, 1991.
38. Lavoie PM, Thibodeau J, Cloutier I, Busch R, Sékaly RP: Selective binding of bacterial toxins to major histocompatibility complex class !!-expressing cells is controlled by invariant chain and HLA-DM. Proc Natl Acad Sci USA (in press).
39. Karp DR, Jenkins RN, Long EO: Distinct binding sites on HLA-DR for invariant chain and staphylococcal enterotoxins. Proc Natl Acad Sci USA 89:9657, 1992.
40. Ericson ML, Sundstrom M, Sansom DM, Charron DJ: Mutually exclusive binding of peptide and invariant chain to major histocompatibility complex class II antigens. J Biol Chem 269:26531, 1994.
41. Baccala R, Vandekerckhove BA, Jones D, Kono DH, Roncarolo MG, Theofilopoulos AN: Bacterial superantigens mediate T cell deletions in the mouse severe combined immunodeficiency-human liver/thymus model. J Exp Med 177:1481, 1993.
42. McCormack JE, Callahan JE, Kappler J, Marrack PC: Profound deletion of mature T cells in vivo by chronic exposure to exogenous superantigen. J Immunol 150: 3785, 1993.
43. Liu H, Lampe MA, Iregui MV, Cantor H: Conventional antigen and superantigen may be coupled to distinct and cooperative T-cell activation pathways. Proc Natl Acad Sci USA 88:8705, 1991.
44. Weber GF, Abromson-Leeman SR, Cantor H: A signaling pathway coupled to T cell receptor ligation by MMTV superantigen leading to transient activation and programmed cell death. Immunity 2:363, 1995.
45. Choi Y, Kotzin B, Herron L, Callahan J, Marrack P, Kappler J: Interaction of Staphylococcus aureus toxin 'superantigens' with human T cells. Proc Natl Acad Sci USA 86:8941, 1989.
46. a. Cell 61:1365, 1990.
47. Fields BA, Malchiodi EL, Li HM, Ysern X, Stauffacher CV, Schlievert PM, Karjalainen K, Mariuzza RA: Crystal structure of a T-cell receptor beta-chain complexed with a superantigen. Nature 384:188, 1996.
48. Davis MM: T-cell receptors: serial engagement proposed. Nature 375:104, 1995.
49. Lanzavecchia A, Reid PA, Watts C: Irreversible association of peptides with class II MHC molecules in living cells. Nature 357:249, 1992.
50. Valitutti S, Müller S, Cella M, Padovan E, Lanzavecchia A: Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature 375:148, 1995.
51. Malchiodi EL, Eisenstein E, Fields BA, Ohlendorf DH, Schlievert PM, Karjalainen K, Mariuzza RA: Superantigen binding to a T cell receptor β chain of known three-dimensional structure. J Exp Med 182:1833, 1995.
52. Viola A, Lanzavecchia A: T cell activation determined by T cell receptor number and tunable thresholds. Science 273:104, 1996.
53. Elliott EA, Drake JR, Amigorena S, Elsemore J, Webster P, Mellman I, Flavell RA: The invariant chain is required for intracellular transport and function of major histocompatibility complex class II molecules. J Exp Med 179:681, 1994.
54. Labrecque N, Thibodeau J, Mourad W, Sekaly R-P: T cell receptor-major histocompatibility complex class II interaction is required for the T cell response to bacterial superantigens. J Exp Med 180:1921, 1994.
55. Deckhut AM, Chien Y-H, Blackman MA, Woodland DL: Evidence for a functional interaction between the β chain of major histocompatibility complex class II and the T cell receptor α chain during recognition of a bacterial superantigen. J Exp Med 180:1931, 1994.
56. Newton DW, Dohlsten M, Olsson C, Segren S, Lundin KEA, Lando PA, Kalland T, Kotb M: Mutations in the MHC class II binding domains of staphylococcal enterotoxin A differentially affect T cell receptor Vβ specificity. J Immunol 157:3988, 1996.
57. Sloan-Lancaster J, Evavold BD, Allen PM: Induction of T-cell anergy by altered T-cell receptor ligand on live antigen presenting cells. Nature 363:156, 1993.
58. Madrenas J, Wange RL, Wang JL, Isakov N, Samelson LE, Germain RN: Zeta phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists. Science 267:515, 1995.
59. Niedergang F, Hemar A, Hewitt CR, Owen MJ, Dautry-Varsat A, Alcover A: The Staphylococcus aureus enterotoxin B superantigen induces specific T cell receptor down-regulation by increasing its internalization. J Biol Chem 270:12839, 1995.
60. Dohlsten M, Abrahmsen L, Björk P, Lando PA, Hedlund G, Forsberg G, Brodin T, Gascoigne NRJ, Förberg C, Lind P, et al.: Monoclonal antibody-superantigen fusion proteins: tumor-specific agents for T-cell-based tumor therapy. Proc Natl Acad Sci USA 91:8945, 1994.